TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Ebba Biotech AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
184
|
167
|
134 |
| Financial expenses |
1
|
2
|
1 |
| Earnings before taxes |
-182
|
-163
|
-305 |
| EBITDA |
-174
|
-155
|
-299 |
| Total assets |
116
|
110
|
161 |
| Current assets |
109
|
97
|
145 |
| Current liabilities |
32
|
40
|
73 |
| Equity capital |
17
|
26
|
53 |
| - share capital |
5
|
6
|
6 |
| Employees (average) |
4
|
4
|
4 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
14.7%
|
23.6%
|
32.9% |
| Turnover per employee |
46
|
42
|
34 |
| Profit as a percentage of turnover |
-98.9%
|
-97.6%
|
-227.6% |
| Return on assets (ROA) |
-156.0%
|
-146.4%
|
-188.8% |
| Current ratio |
340.6%
|
242.5%
|
198.6% |
| Return on equity (ROE) |
-1070.6%
|
-626.9%
|
-575.5% |
| Change turnover |
23
|
33
|
29 |
| Change turnover % |
14%
|
24%
|
28% |
| Chg. No. of employees |
0
|
0
|
1 |
| Chg. No. of employees % |
0%
|
0%
|
33% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.